Old Web
English
Sign In
Acemap
>
authorDetail
>
K Smirnakis
K Smirnakis
Biogen Idec
Placebo
Lupus erythematosus
Plasmacytoid dendritic cell
Medicine
Pharmacodynamics
3
Papers
9
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
SAT0235 BIIB059, a monoclonal antibody targeting BCDA2 shows safety, tolerability, pharmacokinetics, pharmacodynamics in healthy volunteer subjects
2017
Annals of the Rheumatic Diseases
D Martin
L Stevenson
P Prasad
K Smirnakis
A Kao
Dania Rabah
W Wang
C. Barbey
C. Musselli
Nathalie Franchimont
Show All
Source
Cite
Save
Citations (0)
SAT0222 BIIB059, a monoclonal antibody targeting BDCA2, shows evidence of biological activity and early clinical proof of concept in subjects with active cutaneous le
2017
Annals of the Rheumatic Diseases
Richard Furie
Victoria P. Werth
Joseph F. Merola
Taylor L. Reynolds
L Stevenson
W Wang
K Smirnakis
C. Barbey
C. Musselli
B. Werneburg
Dania Rabah
Nathalie Franchimont
Show All
Source
Cite
Save
Citations (7)
83 Biib059, a monoclonal antibody targeting bdca2, demonstrates evidence of proof of biological activity in subjects with cutaneous lupus
2017
Lupus science & medicine
Richard Furie
Victoria P. Werth
Joseph F. Merola
W Wang
Dania Rabah
C. Barbey
K Smirnakis
B. Werneburg
J Bornstein
Taylor L. Reynolds
L Stevenson
Nathalie Franchimont
Show All
Source
Cite
Save
Citations (2)
1